Biomarkers Market Worth $45.55 Billion by 2020
DALLAS, July 17, 2015 /PRNewswire/ --
According to a new market research report "Biomarkers Market by Product (Consumables, Services), by Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine), Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020", published by MarketsandMarkets, the global Biomarkers Market will be valued at $24.10 Billion in 2015. It is expected to grow at a CAGR of 13.58% to reach $45.55 Billion by 2020.
Browse 93 market data Tables and 102 Figures spread through 178 Pages and in-depth TOC on "Biomarkers Market"
Early buyers will receive 10% customization on this report.
Increasing healthcare and R&D expenditure are the key growth drivers in this market. However, poorly suited regulatory & reimbursement systems, high cost of tests and sample collection & storage may hinder the growth of this market.
The global Biomarkers Market is segmented on the basis of product, type of biomarker, application, and disease indication. On the basis of application, the market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and others. Of these, diagnostics development accounted for the largest share of the global Biomarkers Market in 2015. On the other hand, personalized medicine is expected to grow at the highest rate.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=43
By product, the market is divided into consumables, services, and software. Of these, consumables accounted for the largest share and are expected to show the highest growth. On the basis of type, the Biomarkers Market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. On the basis of disease indications, the Biomarkers Market is categorized into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW).
The major players in Biomarkers Market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Enzo Biochem (U.S.), EKF Diagnostics Holdings plc (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Browse Related Reports:
Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019.
http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018.
http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html
About MarketsandMarkets:
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Share this article